Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren Schwartz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Australian Prescriber|October 22, 2019
Stopping and switching antipsychotic drugsNicholas Keks, Darren Schwartz, Judy Hope
Australian Prescriber|October 22, 2019
Antipsychotic switching toolNicholas Keks, Darren Schwartz, Judy Hope
CNS Drugs|April 5, 2020
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for SchizophreniaNicholas Keks, Judith Hope, Darren Schwartz, et al.
British Journal of Clinical Pharmacology|April 15, 2016
The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysisAmy T Page, Rhonda M Clifford, Kathleen Potter, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Australian Prescriber|October 22, 2019
Stopping and switching antipsychotic drugsNicholas Keks, Darren Schwartz, Judy Hope
Australian Prescriber|October 22, 2019
Antipsychotic switching toolNicholas Keks, Darren Schwartz, Judy Hope
CNS Drugs|April 5, 2020
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for SchizophreniaNicholas Keks, Judith Hope, Darren Schwartz, et al.
British Journal of Clinical Pharmacology|April 15, 2016
The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysisAmy T Page, Rhonda M Clifford, Kathleen Potter, et al.
Pageof 1